Search research articles
Contact Us
Filters
Showing results (711-720 of 1,253) with videos related to
Page
of 126
Sort By:
Journal of the American College of Cardiology
|
August 1, 1996
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients
E D Peterson, W R Hathaway, K M Zabel, et al.
Circulation. Cardiovascular Quality and Outcomes
|
September 3, 2010
Impact of a statewide ST-segment-elevation myocardial infarction regionalization program on treatment times for women, minorities, and the elderly
Seth W Glickman, Christopher B Granger, Fang-Shu Ou, et al.
American Heart Journal
|
July 12, 2011
Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction"
John K French, Paul W Armstrong, Eric Cohen, et al.
American Heart Journal
|
December 16, 2014
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Christopher B Granger, Renato D Lopes, Michael Hanna, et al.
Journal of Cardiovascular Translational Research
|
August 15, 2015
A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN Experience
William E Kraus, Christopher B Granger, Michael H Sketch, et al.
European Heart Journal
|
January 18, 2006
Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes
Andrés Orlandini, Rafael Díaz, Daniel Wojdyla, et al.
Circulation
|
August 20, 2003
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial
Kenneth W Mahaffey, Christopher B Granger, Jose C Nicolau, et al.
Circulation. Cardiovascular Quality and Outcomes
|
May 17, 2012
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights
Sean van Diepen, Petr Widimsky, Renato D Lopes, et al.
The American Journal of Cardiology
|
September 29, 2005
Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events)
Michael J Lim, Kim A Eagle, Joel M Gore, et al.
The New England Journal of Medicine
|
October 27, 1994
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States
D B Mark, C D Naylor, M A Hlatky, et al.
Page
of 126
Search research articles
Search
Showing results (711-720 of 1,253) with videos related to
Sort By:
Page
of 126
Journal of the American College of Cardiology
|
August 1, 1996
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients
E D Peterson, W R Hathaway, K M Zabel, et al.
Circulation. Cardiovascular Quality and Outcomes
|
September 3, 2010
Impact of a statewide ST-segment-elevation myocardial infarction regionalization program on treatment times for women, minorities, and the elderly
Seth W Glickman, Christopher B Granger, Fang-Shu Ou, et al.
American Heart Journal
|
July 12, 2011
Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction"
John K French, Paul W Armstrong, Eric Cohen, et al.
American Heart Journal
|
December 16, 2014
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Christopher B Granger, Renato D Lopes, Michael Hanna, et al.
Journal of Cardiovascular Translational Research
|
August 15, 2015
A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN Experience
William E Kraus, Christopher B Granger, Michael H Sketch, et al.
European Heart Journal
|
January 18, 2006
Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes
Andrés Orlandini, Rafael Díaz, Daniel Wojdyla, et al.
Circulation
|
August 20, 2003
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial
Kenneth W Mahaffey, Christopher B Granger, Jose C Nicolau, et al.
Circulation. Cardiovascular Quality and Outcomes
|
May 17, 2012
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights
Sean van Diepen, Petr Widimsky, Renato D Lopes, et al.
The American Journal of Cardiology
|
September 29, 2005
Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events)
Michael J Lim, Kim A Eagle, Joel M Gore, et al.
The New England Journal of Medicine
|
October 27, 1994
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States
D B Mark, C D Naylor, M A Hlatky, et al.
Page
of 126